BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19345206)

  • 1. Anti-inflammatory effects and gastrointestinal safety of NNU-hdpa, a novel dual COX/5-LOX inhibitor.
    Xu GL; Liu F; Ao GZ; He SY; Ju M; Zhao Y; Xue T
    Eur J Pharmacol; 2009 Jun; 611(1-3):100-6. PubMed ID: 19345206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of inflammatory mediators contributes to the anti-inflammatory activity of KYKZL-1 via MAPK and NF-κB pathway.
    Xu GL; Du YF; Cheng J; Huan L; Chen SC; Wei SH; Gong ZN; Cai J; Qiu T; Wu H; Sun T; Ao GZ
    Toxicol Appl Pharmacol; 2013 Oct; 272(1):221-9. PubMed ID: 23732080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological evaluation of 2-(4-amino-phenyl)-3-(3,5-dihydroxylphenyl) propenoic acid.
    Xu GL; Liu F; Zhao Y; Ao GZ; Xi L; Ju M; Xue T
    Basic Clin Pharmacol Toxicol; 2009 Nov; 105(5):350-6. PubMed ID: 19744157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive effect of crocin in inflamed animals and in LPS-challenged RAW 264.7 cells.
    Xu GL; Li G; Ma HP; Zhong H; Liu F; Ao GZ
    J Agric Food Chem; 2009 Sep; 57(18):8325-30. PubMed ID: 19754168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological evaluation and molecular docking of new di-tert-butylphenol compound, LQFM-091, a new dual 5-LOX/COX inhibitor.
    Lino RC; da Silva DPB; Florentino IF; da Silva DM; Martins JLR; Batista DDC; Leite KCS; Villavicencio B; Vasconcelos GA; Silva ALP; de Ávila RI; Verli H; Valadares MC; Gil ES; Vaz BG; Lião LM; Menegatti R; Costa EA
    Eur J Pharm Sci; 2017 Aug; 106():231-243. PubMed ID: 28599988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The different inhibitory effects of Huang-Lian-Jie-Du-Tang on cyclooxygenase 2 and 5-lipoxygenase.
    Li L; Zeng H; Shan L; Yuan X; Li Y; Liu R; Zhang W
    J Ethnopharmacol; 2012 Sep; 143(2):732-9. PubMed ID: 22884869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity.
    Shrivastava SK; Srivastava P; Bandresh R; Tripathi PN; Tripathi A
    Bioorg Med Chem; 2017 Aug; 25(16):4424-4432. PubMed ID: 28669741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel N-substituted 5-aminosalicylamides as dual inhibitors of cyclooxygenase and 5-lipoxygenase enzymes: Synthesis, biological evaluation and docking study.
    El-Nagar MKS; Abdu-Allah HHM; Salem OIA; Kafafy AN; Farghaly HSM
    Bioorg Chem; 2018 Aug; 78():80-93. PubMed ID: 29550533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
    Horizoe T; Nagakura N; Chiba K; Shirota H; Shinoda M; Kobayashi N; Numata H; Okamoto Y; Kobayashi S
    Inflamm Res; 1998 Oct; 47(10):375-83. PubMed ID: 9831321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series.
    Song Y; Connor DT; Doubleday R; Sorenson RJ; Sercel AD; Unangst PC; Roth BD; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
    J Med Chem; 1999 Apr; 42(7):1151-60. PubMed ID: 10197959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 2. 1,3,4- and 1,2,4-thiadiazole series.
    Song Y; Connor DT; Sercel AD; Sorenson RJ; Doubleday R; Unangst PC; Roth BD; Beylin VG; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
    J Med Chem; 1999 Apr; 42(7):1161-9. PubMed ID: 10197960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of 2,5-disubstituted 1,3,4-oxadiazole derivatives with both COX and LOX inhibitory activity.
    Akhter M; Akhter N; Alam MM; Zaman MS; Saha R; Kumar A
    J Enzyme Inhib Med Chem; 2011 Dec; 26(6):767-76. PubMed ID: 21314246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of anti-inflammatory activity of umbelliferone 6-carboxylic acid isolated from Angelica decursiva.
    Islam MN; Choi RJ; Jin SE; Kim YS; Ahn BR; Zhao D; Jung HA; Choi JS
    J Ethnopharmacol; 2012 Oct; 144(1):175-81. PubMed ID: 22981803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
    Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
    J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of anti-inflammatory and immunomodulatory effects of Premna integrifolia extracts and assay-guided isolation of a COX-2/5-LOX dual inhibitor.
    Azad R; Babu NK; Gupta AD; Reddanna P
    Fitoterapia; 2018 Nov; 131():189-199. PubMed ID: 30339925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanism of capillarisin-mediated inhibition of MyD88/TIRAP inflammatory signaling in in vitro and in vivo experimental models.
    Khan S; Choi RJ; Shehzad O; Kim HP; Islam MN; Choi JS; Kim YS
    J Ethnopharmacol; 2013 Jan; 145(2):626-37. PubMed ID: 23237934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory activity of myricetin-3-O-beta-D-glucuronide and related compounds.
    Hiermann A; Schramm HW; Laufer S
    Inflamm Res; 1998 Nov; 47(11):421-7. PubMed ID: 9865500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atropa acuminata Royle Ex Lindl. blunts production of pro-inflammatory mediators eicosanoids., leukotrienes, cytokines in vitro and in vivo models of acute inflammatory responses.
    Nisar A; Malik AH; Zargar MA
    J Ethnopharmacol; 2013 Jun; 147(3):584-94. PubMed ID: 23528361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New benzothiophene derivatives as dual COX-1/2 and 5-LOX inhibitors: synthesis, biological evaluation and docking study.
    El-Miligy MM; Hazzaa AA; El-Messmary H; Nassra RA; El-Hawash SA
    Future Med Chem; 2017 Apr; 9(5):443-468. PubMed ID: 28362117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.